does ERP work for OCD?

if you have spent a week reading about intrusive thoughts, you have met three questions in a row: is this OCD, does exposure and response prevention actually work, and is it therapy or medication or both. the trials answer the second one well, the third one with a caveat that most pages leave out, and the first one only in part. here is the record, the strongest case against the headline number, and what to ask.

five questions, answered from the trials

what the 14 points mean

the Y-BOCS runs from 0 to 40, and a 14-point drop is the difference between a day organised around the compulsions and a day with room in it. that number came from 11 trials and 287 people, which is small next to the 3,158 people in the SSRI trials, and the credible interval around it is wide (−18.6 to −10.2).^[1] it is still the biggest effect in the network by a factor of three over the best drug, and the 37-trial meta-analysis, built differently, lands in the same place.^[2] the treatment is also specific: exposure to the feared thought or situation, with the ritual withheld, repeated until the fear drops on its own. talk therapy that discusses the obsessions is not the thing that was tested.

the other direction

three things cut against the headline. first, 12 of the 15 psychotherapy trials in the network explicitly allowed antidepressants, so the therapy effect was mostly measured on top of medication, not instead of it; the authors call that a serious limitation and conclude the combination probably beats therapy alone in severe OCD.^[1] second, the 37-trial authors say the trials have a number of methodological problems, and their largest effect sizes are against waiting lists and placebo conditions, which is the easiest comparison to win.^[2] third, the head-to-head response rate was 62 percent among everyone treated, which means 38 percent did not respond to twelve weeks of intensive ERP, and the network excluded treatment-resistant populations altogether.^[1][3] the trials also treated OCD as one condition: none of the abstracts read for this page reports results by theme, so the subtype you recognise yourself in below has no separate number.

the themes people post about

in a week of reading the OCD forums, half the posts were about a subtype rather than the diagnosis. these are the recurring ones. the trials above did not separate them; the diagnosis and the treatment are the same across all of them, and the thing that makes a thought an obsession is not its content but the loop it sits in.

the phrase “i’m so OCD” is graded in the mental-health lexicon: a disabling diagnosis borrowed as a word for tidy, and the survey that shows why the borrowing is easy is the same one cited above.^[4]

what to ask before the first session

five questions, each with the reason it works. if you are still choosing who to ask, how to find the right therapist covers how much the therapist matters and the switch rule, and how long should therapy take has the dose numbers; OCD sat at the longer end of that range, 6 to 16 sessions of high-intensity work.

questions people ask

sources

1. Skapinakis P, Caldwell DM, Hollingworth W, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 2016;3(8):730-739. 54 trials, 6,652 participants; outcome Y-BOCS, mean difference against placebo with 95% credible intervals. Behavioural therapy −14.48 (−18.61 to −10.23; 11 trials, 287 patients); cognitive therapy −13.36 (−18.40 to −8.21; 6 trials, 172); behavioural therapy plus clomipramine −12.97 (−19.18 to −6.74; one trial, 31); CBT −5.37 (−9.10 to −1.63; 9 trials, 231); clomipramine −4.72 (−6.85 to −2.60; 13 trials, 831); all SSRIs as a class −3.49 (−5.12 to −1.81; 37 trials, 3,158). Clomipramine was not better than SSRIs (−1.23, −3.41 to 0.94). “Psychotherapeutic interventions had a greater effect than did medications, but a serious limitation was that most psychotherapeutic trials included patients who were taking stable doses of antidepressants (12 [80%] of the 15 psychotherapy trials explicitly allowed antidepressants).” Interpretation: the combination “is likely to be more effective than are psychotherapeutic interventions alone, at least in severe obsessive-compulsive disorder.” Treatment-resistant populations were excluded. Funded by the UK National Institute for Health Research. PMID 27318812. https://doi.org/10.1016/S2215-0366(16)30069-4
2. Öst LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clinical Psychology Review 2015;40:156-169. 37 randomised trials using the interviewer-rated Y-BOCS. Effect sizes: CBT against waiting list 1.31 and against placebo 1.33 (“very large”); individual against group treatment 0.17 and exposure and response prevention against cognitive therapy 0.07 (“small and non-significant”); CBT “significantly better than antidepressant medication (0.55), but the combination of CBT and medication was not significantly better than CBT plus placebo (0.25).” “The RCTs have a number of methodological problems.” PMID 26117062. https://doi.org/10.1016/j.cpr.2015.06.003
3. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 2005;162(1):151-161. 122 adult outpatients, three centres, 12 weeks; intensive ERP for four weeks then eight weekly maintenance sessions, clomipramine to 250 mg/day, both, or pill placebo. Response rates (treated / completer): ERP 62% / 86%; clomipramine 42% / 48%; ERP plus clomipramine 70% / 79%; placebo 8% / 10%. “The effect of exposure and ritual prevention did not differ from that of exposure and ritual prevention plus clomipramine, and both were superior to clomipramine only.” PMID 15625214. https://doi.org/10.1176/appi.ajp.162.1.151
4. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Molecular Psychiatry 2010;15(1):53-63. Nationally representative US survey; a subsample of 2,073 respondents assessed for lifetime DSM-IV OCD. “More than one quarter of respondents reported experiencing obsessions or compulsions at some time in their lives”; “only small proportions of respondents met full DSM-IV criteria for lifetime (2.3%) or 12-month (1.2%) OCD.” Severity was associated with poor insight, high comorbidity, high role impairment and a high probability of seeking treatment. PMID 18725912. https://doi.org/10.1038/mp.2008.94
5. Clomipramine hydrochloride capsules, USP. FDA prescribing information, Indications and Usage, label effective 2025-05-13, read through the openFDA drug-label API on 2026-09-25. “Indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning.” https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=clomipramine
6. Fluvoxamine maleate extended-release capsules. FDA prescribing information, section 1, label effective 2025-11-04, read through the openFDA drug-label API on 2026-09-25. “A selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of obsessive compulsive disorder (OCD).” Efficacy shown in one 12-week extended-release study in adults, two 10-week immediate-release studies in adults, one in children and adolescents, and one maintenance study. https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=fluvoxamine

related: what works that costs nothing · what each medication is approved for · “i’m so OCD”, graded · how to find the right therapist

adam